Etanercept is a recombinant Fc fusion protein therapeutic, targeting inflammation regulation. It binds to the receptors TNFR and p75 to block adverse inflammation at the cellular level and has a complex distribution of post-translation modifications (PTM), such as N and O-linked glycans…
Session Speaker
Bioprocessing Technology Institute, A*STAR Research Entities